EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark EVOX THERAPEUTICS was filed as Word mark on 09/04/2020 at the European Union Intellectual Property Office.
It was registered as a trademark on 05/29/2021.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018303005 |
| Application date | September 4, 2020 |
| Publication date | February 19, 2021 |
| Entry date | May 29, 2021 |
| Expiration date | September 4, 2030 |
Trademark owner
Oxford Science Park, Medawar Centre, 2nd Floor East Building, Robert Robinson Avenue
OX4 4HG Oxford
GB
OX4 4HG Oxford
GB
Trademark representatives
9 RUE PONTARIQUE
47000 AGEN
FR
goods and services
5
Chemical reagents; Pharmaceuticals; pharmaceutical preparations and substances; pharmaceutical preparations, namely, a drug delivery system comprising genetically engineered or purified exosomes for therapeutic use; pharmaceutical preparations, namely, exosomes to deliver protein for genetic therapy; medicine; medical preparations and articles; biological preparations for medical purposes; biological preparations for the treatment of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies such as mitochondrial disease, joint/ligament strain/tears, muscle atrophy, muscular dystrophy; biological preparations comprising exosome; biological preparations comprising a therapeutic target protein-loaded exosome; biological preparations comprising exosome for pharmaceutical purposes; biological reagents for medical use; mixed biological preparations for medical purposes; mixed biological preparations for the prevention and treatment of infectious diseases; pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, EV-based nucleic acid therapeutics for the prevention and treatment of infections or disease; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays that test for the presence of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies such as mitochondrial disease, joint/ligament strain/tears, muscle atrophy, muscular dystrophy; none of the aforesaid goods being exclusively for use in relation to the development and production of industrial enzymes or probiotics used in food and drinks applications
42
Scientific, medical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; research and analysis services; biological research; clinical research; providing medical and scientific research information in the field of filtration of exosomes from blood; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of infectious diseases and metabolic disorders; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; information, advisory and consultancy services in relation to the aforesaid; none of the aforesaid services being exclusively for use in relation to the development and production of industrial enzymes or probiotics used in food and drinks applications
44
Medical services; medical and pharmaceutical consultancy; medical services relating to the diagnosis and treatment of persons; laboratory analysis service relating to the diagnosis and treatment of persons; medical analysis and examinations; medical treatment services; medical screening; medical monitoring, testing, inspection and analysis services relating to the diagnosis and treatment of viral and bacterial based infections and diseases; medical monitoring, testing, inspection and analysis services relating to the diagnosis and treatment of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies such as mitochondrial disease, joint/ligament strain/tears, muscle atrophy, muscular dystrophy; information, advisory and consultancy services in relation to the aforesaid
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| September 22, 2023 | Change Representative, Published | ||
| March 31, 2021 | Change Representative, Registered |
ID: 11018303005